We have recommended the first under-the-tongue tablet immunotherapy shown to build long-term tolerance to allergens, which could help up to 27,000 people in England with moderate to severe birch tree ...

Evidence-based recommendations on vanzacaftor-tezacaftor-deutivacaftor (Alyftrek) for treating cystic fibrosis in people 6 years and over with an F508del mutation in the cystic fibrosis transmembrane ...

How NICE International is supporting evidence-based decision-making through the Regulatory Partnership for Growth Fund ...

After four years of transformational leadership, NICE CEO Dr Sam Roberts will step down at the end of the year to support her children through a difficult time.

COVID-19 All NICE products on COVID-19. Includes any guidance and advice. Published products on this topic (13) ...

Late-stage assessment (LSA) guidance on intermittent urethral catheters for chronic incomplete bladder emptying in adults. Last reviewed: 09 July 2025 Guidance development process NICE LSA guidance ...

A quick guide for care home managers More than half of older adults who live in care homes have tooth decay, compared to 40% of over 75s who do not live in care homes. Poor oral health can affect ...